GlassScriptPhysician profile
Arlene J Donowitz
NPI 1548247109
$6,790.65
in general payments reported to CMS, 2019-2025
41 companies · $840 in 2025
The $840 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $787 · 2021: $1,310 · 2022: $1,072 · 2023: $848 · 2024: $885 · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,463 · Education: $60.00 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,463.42 |
| Education | $60.00 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $951.37 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $750.21 | 2019-2025 | |
| Abbvie INC. | $687.45 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Glaxosmithkline, LLC. | $603.67 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $503.88 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $395.56 | 2019-2025 | |
| Abbott Laboratories | $390.33 | 2022-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Astellas Pharma US INC | $371.65 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $343.34 | 2019-2024 | Repatha, Otezla, Prolia |
| Astrazeneca Pharmaceuticals LP | $190.96 | 2019-2025 | Farxiga, Airsupra |
| Biohaven Pharmaceuticals, INC. | $154.98 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.84 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.44 | 2021-2024 | Xifaxan, Trulance |
| Sunovion Pharmaceuticals INC. | $114.05 | 2021-2022 | |
| Inspire Medical Systems, INC. | $88.62 | 2023-2024 | Inspire |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Donowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.